Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment

Type 2 diabetes mellitus (T2DM) therapy is facing the challenges of long-term medication and gradual destruction of pancreatic islet β-cells. Therefore, it is timely to develop oral prolonged action formulations to improve compliance, while restoring β-cells survival and function. Herein, we designe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Lin, Peng, Xueyuan, Wang, Ruiting, Wang, Yifei, Li, Hong, Zhang, Huijuan, Zhang, Yun, Zhang, Zhenzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373096/
https://www.ncbi.nlm.nih.gov/pubmed/37521855
http://dx.doi.org/10.1016/j.apsb.2022.12.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373096/
https://www.ncbi.nlm.nih.gov/pubmed/37521855
http://dx.doi.org/10.1016/j.apsb.2022.12.014

Ejemplares similares